skip to main content


Title: Curcumin Downregulates the Expression of p44/42 MAPK and Causes Caspase-mediated Cell Inhibition in MCF-7 Breast Cancer Cells
Curcumin is a derivative of the turmeric spice, which is a yellow-pigmented root crop with a resilient sheath and bright orange flesh. It is originally known to be utilized in Asian dishes but, has been discovered to have antioxidant, anti-inflammatory, antiviral, antibacterial and anticancer characteristics. Different researchers have established great possibilities of curcumin's ability to prohibit the growth of cancer cells especially, because of its potentiality to differentiate between normal and cancerous cells. Research questions include understanding the effects of curcumin on the MCF-7 breast cancer cells with regards to the biomolecules of the cells. The results indicated that after attachment of cells for 48 hours, the concentration of curcumin at 15 µM showed more than 90% inhibition of cells within 24 hours. The analysis was carried out on the viability of the cells, western blotting and reverse transcriptase-polymerase chain reaction. Western blot analysis of signaling proteins from curcumin-treated cells showed that the expression level of phosphorylated protein p44/42 in the MAP kinase pathway was significantly decreased and the apoptotic marker cleaved caspase 3 was increased as compared to the curcumin-untreated control cells. Moreover, RT-PCR analysis of the reference genes in the apoptotic pathway (p53, caspase 9, BCL-2 and Bax) demonstrated the upregulation of p53, Bax and caspase 9 genes. The results assembled from this present study suggested that curcumin inhibited the growth and induced caspase-mediated apoptosis of MCF-7 cells via the MAPK signaling pathway. Therefore, breast cancer treatment with curcumin seems to be a promising remedial path in near future.  more » « less
Award ID(s):
1719607
NSF-PAR ID:
10143040
Author(s) / Creator(s):
; ;
Date Published:
Journal Name:
Bioresearch communications
Volume:
6
Issue:
1
ISSN:
2411-0485
Page Range / eLocation ID:
801-805
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. Nanoparticles have been widely used as remedies for disorders for a long time. They are 10-9 m specks of substances that can be found both naturally and synthesized in the laboratory with metal and nonmetal materials. In this study, gold nanoparticles (AuNPs) were synthesized using the citrate reduction method, and the 35 nm size of the nanoparticles was determined using a UV-Vis Spectrophotometer at 525 nm wavelength. The synthesized nanoparticles were further studied on MCF-7 breast cancer cells to understand how various genes are expressed in the induction of apoptosis in signal transduction pathways. The results obtained from the anticancer activity of the gold nanoparticles showed approximately 90% inhibition of cell growth after 72 hours of treatment. Western blot analysis demonstrated the downregulation of p44/42 MAPK (ERK1/2) protein due to gold nanoparticle treatment. Moreover, reverse transcription-polymerase chain reaction (RT-PCR) analysis of apoptotic genes revealed the upregulation of the p53 tumor suppressor gene, Bax, and caspase-9. The results assembled from this study further indicates that p44/42 MAPK, p53, caspase 9 and Bax play a major role in the mechanism of apoptosis in the MCF-7 breast cancer cells. 
    more » « less
  2. Three new organotin( iv ) carboxylate compounds were synthesized and structurally characterized by elemental analysis and FT-IR and multinuclear NMR ( 1 H, 13 C, 119 Sn) spectroscopy. Single X-ray crystallography reveals that compound C2 has a monoclinic crystal system with space group P 2 1 / c having distorted bipyramidal geometry defined by C 3 SnO 2 . The synthesized compounds were screened for drug-DNA interactions via UV-Vis spectroscopy and cyclic voltammetry showing good activity with high binding constants. Theoretical investigations also support the reactivity of the compounds as depicted from natural bond orbital (NBO) analysis using Gaussian 09. Synthesized compounds were initially evaluated on two cancer (HeLa and MCF-7) cell lines and cytotoxicity to normal cells was evaluated using a non-cancerous (BHK-21) cell line. All the compounds were found to be active, with IC 50 values less than that of the standard drug i.e. cisplatin. The cytotoxic effect of the most potent compound C2 was confirmed by LDH cytotoxicity assay and fluorescence imaging after PI staining. Apoptotic features in compound C2 treated cancer cells were visualized after DAPI staining while regulation of apoptosis was observed by reactive oxygen species generation, binding of C2 with DNA, a change in mitochondrial membrane potential and expression of activated caspase-9 and caspase-3 in cancer cells. Results are indicative of activation of the intrinsic pathway of apoptosis in C2 treated cancer cells. 
    more » « less
  3. Abstract

    Mitomycin C (MC) is a well‐knownDNAalkylating agent.MCanalog, 10‐decarbamoyl mitomycin C (DMC), unlikeMC, has stronger effects on cancer with p53 mutation. We previously demonstrated thatMC/DMCcould activate p21WAF1/CIP1inMCF‐7 (p53‐proficient) and K562 (p53‐deficient) cells in a p53‐independent mode. This study aimed to elucidate the upstream signaling pathway of p21WAF1/CIP1activation triggered byMC/DMC. Besides p53, Akt plays an important role on deactivating p21WAF1/CIP1. The results showed thatMC/DMCinhibited Akt inMCF‐7 cells, but not in K562 cells. By knocking down p53, the Akt inhibition inMCF‐7 cells was alleviated. This implied that the deactivated Akt caused byMC/DMCwas p53‐dependent. With Akt activator (SC79), p21WAF1/CIP1activation triggered byMC/DMCinMCF‐7 cells was not reduced. This indicated that Akt inhibition triggered byMC/DMCwas not associated withMC/DMC‐induced p21WAF1/CIP1activation. Label‐free quantitative proteomic profiling analysis revealed thatDMChas a stronger effect on down‐regulating thePI3K/Akt signaling pathway inMCF‐7 cells as compared toMC. No significant effect ofMC/DMConPI3K/Akt in K562 cells was observed. In summary,MC/DMCregulate Akt activation in a p53‐dependent manner. This Akt deactivation is not associated with p21WAF1/CIP1activation in response toMC/DMC.

     
    more » « less
  4. Abstract Breast cancer metastasis occurs via blood and lymphatic vessels. Breast cancer cells ‘educate’ lymphatic endothelial cells (LECs) to support tumor vascularization and growth. However, despite known metabolic alterations in breast cancer, it remains unclear how lymphatic endothelial cell metabolism is altered in the tumor microenvironment and its effect in lymphangiogenic signaling in LECs. We analyzed metabolites inside LECs in co-culture with MCF-7, MDA-MB-231, and SK-BR-3 breast cancer cell lines using $$^1\hbox {H}$$ 1 H nuclear magnetic resonance (NMR) metabolomics, Seahorse, and the spatial distribution of metabolic co-enzymes using optical redox ratio imaging to describe breast cancer-LEC metabolic crosstalk. LECs co-cultured with breast cancer cells exhibited cell-line dependent altered metabolic profiles, including significant changes in lactate concentration in breast cancer co-culture. Cell metabolic phenotype analysis using Seahorse showed LECs in co-culture exhibited reduced mitochondrial respiration, increased reliance on glycolysis and reduced metabolic flexibility. Optical redox ratio measurements revealed reduced NAD(P)H levels in LECs potentially due to increased NAD(P)H utilization to maintain redox homeostasis. $$^{13}\hbox {C}$$ 13 C -labeled glucose experiments did not reveal lactate shuttling into LECs from breast cancer cells, yet showed other $$^{13}\hbox {C}$$ 13 C signals in LECs suggesting internalized metabolites and metabolic exchange between the two cell types. We also determined that breast cancer co-culture stimulated lymphangiogenic signaling in LECs, yet activation was not stimulated by lactate alone. Increased lymphangiogenic signaling suggests paracrine signaling between LECs and breast cancer cells which could have a pro-metastatic role. 
    more » « less
  5. ABSTRACT

    EseN is anEdwardsiella ictaluritype III secretion system effector with phosphothreonine lyase activity. In this work, we demonstrate that EseN inactivates p38 and c-Jun-N-terminal kinase (JNK) in infected head-kidney-derived macrophages (HKDMs). We have previously reported inactivation of extracellular-regulated kinase 1/2 (ERK1/2). Also, for the first time, we demonstrated that EseN is involved in the inactivation of 3-phosphoinositide-dependent kinase 1 (PDK1), which has not been previously demonstrated for any of the EseN homologs in other species. We also found that EseN significantly affected mRNA expression ofIL-10, pro-apoptoticbaxa, andp53, but had no significant effect on anti-apoptoticbcl2or pro-apoptotic apoptotic peptidase activating factor 1. EseN is also involved in the inhibition of caspase-8 and caspase-3/7 but does not affect caspase-9 activity. Repression of apoptosis was further confirmed with flow cytometry using Alexa Fluor 647-labeled annexin V and propidium iodide. In addition, we found that theE. ictaluriT3SS is essential for the inhibition of IL-1β maturation, but EseN is not involved in this process. EseN did not affect cell pyroptosis, as indicated by the lack of EseN impact on the release of lactate dehydrogenase from infected HKDM. The transmission electron microscopy data also indicate that HKDM infected with WT or aneseNmutant died by apoptosis, while HKDM infected with the T3SS mutant more likely died by pyroptosis. Collectively, our results indicate thatE. ictaluriEseN is involved in inactivation of ERK1/2, p38, JNK, and PDK1 signaling pathways that lead to modulation of cell death among infected HKDMs.

    IMPORTANCE

    This work has global significance in the catfish industry, which provides food for increasing global populations.E. ictaluriis a leading cause of disease loss, and EseN is an important player inE. ictalurivirulence. TheE. ictaluriT3SS effector EseN plays an essential role in establishing infection, but the specific role EseN plays is not well characterized. EseN belongs to a family of phosphothreonine lyase effectors that specifically target host mitogen activated protein kinase (MAPK) pathways important in regulating host responses to infection. No phosphothreonine lyase equivalents are known in eukaryotes, making this family of effectors an attractive target for indirect narrow-spectrum antibiotics. Targeting of major vault protein and PDK1 kinase by EseN has not been reported in EseN homologs in other pathogens and may indicate unique functions ofE. ictaluriEseN. EseN targeting of PDK1 is particularly interesting in that it is linked to an extraordinarily diverse group of cellular functions.

     
    more » « less